Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Available 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1

Study Type

Interventional 2Expanded_access 1

Sponsor

Cancer Type

Sarcoma 3

Conditions

Osteosarcoma 3Neoplasms, Bone Tissue 1

Interventions

Methotrexate 21Ifosfamide 21Cyclophosphamide 19Doxorubicin 17Cisplatin 14Filgrastim 13Gemcitabine 12Etoposide 11Leucovorin 9apatinib 8fludarabine 7glucarpidase 6Vincristine 6Temozolomide 6Radiotherapy 6Nivolumab 6Neoadjuvant Therapy 6Drug Therapy 6Carboplatin 6regorafenib 5cabozantinib 5Zoledronic Acid 5Topotecan 5Mesna 5Irinotecan 5Granulocyte Colony-Stimulating Factor 5Docetaxel 5pembrolizumab 4pegfilgrastim 4camrelizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Osteosarcoma × mifamurtide × Clear all
NCT03643133 2026-05-19

SARCOME13

UNICANCER

Phase 2 Active not recruiting
60 enrolled
Sarcoma

Osteosarcoma, Neoplasms, Bone Tissue

NCT04571229 2026-05-11

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Memorial Sloan Kettering Cancer Center

Available
Sarcoma

Osteosarcoma

NCT02441309 2019-09-13

MEMOS

University of Oxford

Phase 2 Terminated
8 enrolled 17 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡